✦ LIBER ✦

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

✍ Scribed by Giacomo Allegrini; Teresa Di Desidero; Maria Teresa Barletta; Anna Fioravanti; Paola Orlandi; Bastianina Canu; Silvio Chericoni; Fotios Loupakis; Antonello Di Paolo; Gianluca Masi; Andrea Fontana; Sara Lucchesi; Giada Arrighi; Mario Giusiani; Andrea Ciarlo; Giovanni Brandi; Romano Danesi; Robert S. Kerbel; Alfredo Falcone; Guido Bocci

Book ID: 113060354
Publisher: Springer
Year: 2012
Tongue: English
Weight: 521 KB
Volume: 15
Category: Article
ISSN: 0969-6970
DOI: 10.1007/s10456-012-9260-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4029 POSTER Phase II clinical trial of m

4029 POSTER Phase II clinical trial of metronomic cyclophosphamide (CTX) plus celecoxib (C) and dexamethasone (DEX) in advanced hormone refractory prostate cancer (HRPC): preliminary clinical and pharmacodynamic results

✍ A. Fontana; G. Bocci; L. Galli; E. Fontana; C. Galli; L. Landi; A. Fioravanti; R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Safety and therapeutic effect of metrono

Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients

✍ Perroud, Herman A; Rico, Maria José; Alasino, Carlos M; Queralt, Francisco; Main 📂 Article 📅 2013 🏛 Future Medicine 🌐 English ⚖ 662 KB

3067 POSTER Irinotecan Metronomic Chemot

3067 POSTER Irinotecan Metronomic Chemotherapy (MC) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical, pharmacodynamic (PD) and pharmacokinetic (PK) evaluation

✍ G. Baldi; G. Bocci; M.T. Barletta; A. Fioravanti; F. Loupakis; P. Orlandi; G. Al 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

7036 Phase II study with pharmacodynamic

7036 Phase II study with pharmacodynamic evaluation of docetaxelprednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) as first line treatment in castration resistant prostate cancer (CRPC)

✍ Fontana, A.; Galli, L.; Derosa, L.; Minuti, G.; D'Arcangelo, M.; Bursi, S.; Land 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

An open, multi-centre, phase II clinical

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

✍ Chao, Y; Li, C P; Chao, T Y; Su, W C; Hsieh, R K; Wu, M F; Yeh, K H; Kao, W Y; C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

Phase I clinical trial to evaluate the s

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

✍ Christopher M. Stephenson, Robert D. Levin… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 242 KB